The Legislature’s Bioscience Caucus has met about a strategic plan to create smart policies that encourage growth in one of Connecticut’s strongest business sectors.  With some of the world’s leading pharmaceutical, medical device, healthcare, insurance and genomics companies in Connecticut, the Caucus says the state is poised to be a leader in one of the most forward-thinking industries. 

Newtown state Senator Tony Hwang says businesses in this field enhance the quality of health and lifestyle, while playing a critical role in economic growth. 

Brookfield Representative Stephen Harding says his goal is to champion important initiatives at the state level to assist bioscience companies, like Boehringer Ingelheim in Ridgebury.  He says investing in bioscience is investing not only in the economy, but in the protection of constituents, environment and animals.